Monitoring non-invasive ventilation at home for patients with Duchenne muscular dystrophy
Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy
This study is testing whether using video and CO2 monitoring at home can help track how well non-invasive ventilation works for people with Duchenne muscular dystrophy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 17 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Trial ID | NCT06773988 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the feasibility of using full video home polysomnography combined with nocturnal transcutaneous CO2 monitoring to follow up on non-invasive ventilation (NIV) in patients with Duchenne muscular dystrophy (DMD). Researchers will evaluate whether adequate measurements can be obtained in a home setting to inform treatment decisions. Additionally, the study will analyze the minimal measurement requirements necessary for effective treatment planning for these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old with Duchenne muscular dystrophy who are currently using non-invasive ventilation.
Not a fit: Patients who are under 18 years old or not using non-invasive ventilation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the management of respiratory care in patients with Duchenne muscular dystrophy, leading to improved patient outcomes.
How similar studies have performed: While this approach is innovative, similar studies have not been widely reported, indicating that this may be a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with DMD \> 18 years using NIV * Signing the written informed consent Exclusion Criteria: * /
Where this trial is running
Leuven, Vlaams-Brabant
- Universitaire Ziekenhuizen KU Leuven — Leuven, Vlaams-Brabant, Belgium (Recruiting)
Study contacts
- Study coordinator: Dries Testelmans, MD PHD
- Email: dries.testelmans@uzleuven.be
- Phone: +3216342522
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.